CPRX..$2.89..I see any pullback being bought here. There is a 20.8% short position on the stock. This stock has catalysts in October and Q4. They also have the breakthrough designation. Shorts trying to put a lid on this are having a hard time. 2 days to cover a 21% short position is not very many days thus the sharp increases in price the past few days as we move closer to the catalysts.
Data Monitoring Committee • DMC charter includes analyses of unblinded safety and efficacy data – Safeguard interests of study participants – Assess the continuing safety & efficacy • i.e. benefit of participation continues to outweigh risks – Provide recommendations for conduct of study – Provide recommendations for continuing or stopping study • Observations and recommendations from latest meeting (03/25/13) – To continue the trial as planned and without changes to the protocol – To continue encouraging greater enrollment rate by adding sites • Next scheduled meeting October, 2013
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.